Country: United States
Language: English
Source: NLM (National Library of Medicine)
liothyronine sodium (UNII: GCA9VV7D2N) (LIOTHYRONINE - UNII:06LU7C9H1V), LEVOTHYROXINE SODIUM (UNII: 9J765S329G) (LEVOTHYROXINE - UNII:Q51BO43MG4)
Allergan, Inc.
liothyronine sodium
LIOTHYRONINE 3.1 ug
ORAL
PRESCRIPTION DRUG
Thyrolar Tablets are indicated: - As replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. This category includes cretinism, myxedema, and ordinary hypothyroidism in patients of any age (children, adults, the elderly), or state (including pregnancy); primary hypothyroidism resulting from functional deficiency, primary atrophy, partial or total absence of thyroid gland, or the effects of surgery, radiation, or drugs, with or without the presence of goiter; and secondary (pituitary), or tertiary (hypothalamic) hypothyroidism (See WARNINGS ). - As pituitary TSH suppressants, in the treatment or prevention of various types of euthyroid goiters, including thyroid nodules, sub-acute or chronic Iymphocytic thyroiditis (Hashimoto's), multinodular goiter, and in the management of thyroid cancer. Thyroid hormone preparations are generally contraindicated in patients with diagnosed but as yet uncorrected adr
Thyrolar Tablets (Liotrix Tablets, USP) are available in five potencies coded as follows: Supplied in bottles of 100, two-layered compressed tablets. Tablets should be stored at cold temperature, between 36˚F and 46˚F (2˚C and 8˚C) in a tight, light- resistant container. Note: (T3 liothyronine sodium is approximately four times as potent as T4 thyroxine on a microgram for microgram basis.) Distributed by: Allergan USA, Inc. Madison, NJ 07940 © 2018 Allergan. All rights reserved. THYROLAR® is a registered trademark of Allergan Sales, LLC. Allergan® and its design are trademarks of Allergan, Inc. Content Updated: June 2018 v.1.0USPI0040
New Drug Application
THYROLAR- LIOTHYRONINE SODIUM, LEVOTHYROXINE SODIUM TABLET ALLERGAN, INC. ---------- THYROLAR TABLETS (LIOTRIX TABLETS, USP) RX ONLY CONTENT UPDATED: JUNE 2018 DESCRIPTION Thyrolar Tablets (Liotrix Tablets, USP) contain triiodothyronine (T liothyronine) sodium and tetraiodothyronine (T levothyroxine) sodium in the amounts listed in the “HOW SUPPLIED” section. (T liothyronine sodium is approximately four times as potent as T thyroxine on a microgram for microgram basis.) The inactive ingredients are calcium phosphate, colloidal silicon dioxide, corn starch, lactose, and magnesium stearate. The tablets also contain the following dyes: Thyrolar ¼ - FD&C Blue #1 and FD&C Red #40; Thyrolar ½ - FD&C Red #40 and D&C Yellow #10; Thyrolar 1 - FD&C Red #40; Thyrolar 2 - FD&C Blue #1, FD&C Red #40, and D&C Yellow #10; Thyrolar 3 - FD&C Red #40 and D&C Yellow #10. STRUCTURAL FORMULAS CLINICAL PHARMACOLOGY The steps in the synthesis of the thyroid hormones are controlled by thyrotropin (Thyroid Stimulating Hormone, TSH) secreted by the anterior pituitary. This hormone's secretion is in turn controlled by a feedback mechanism effected by the thyroid hormones themselves and by thyrotropin releasing hormone (TRH), a tripeptide of hypothalamic origin. Endogenous thyroid hormone secretion is suppressed when exogenous thyroid hormones are administered to euthyroid individuals in excess of the normal gland's secretion. The mechanisms by which thyroid hormones exert their physiologic action are not well understood. These hormones enhance oxygen consumption by most tissues of the body, increase the basal metabolic rate, and the metabolism of carbohydrates, lipids, and proteins. Thus, they exert a profound influence on every organ system in the body and are of particular importance in the development of the central nervous system. The normal thyroid gland contains approximately 200 mcg of levothyroxine (T ) per gram of gland, and ® 3 4 3 4 The normal thyroid gland contains approximately 200 mcg of levothyroxine (T ) per gram of Read the complete document